JI’AN, Jiangxi, China, Sept. 20, 2024 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (the “Company,” “we,” “our” and “us”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its unaudited financial results for the first six months of fiscal year 2024 ended March 31, 2024. Mr. Gang Lai, Chairman of the Board of Directors […]
Category Archives: Pr Newswire
21
Sep
Sep
SOUTH SAN FRANCISCO, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody-drug conjugates (ADCs), today announced that on September 16, 2024, the Compensation Committee of Sutro’s Board of Directors granted 60,000 restricted stock units (RSUs) of Sutro common stock […]
Continuously expanding webmaster signups, especially in multiple regions, along with new highs in webmaster payouts, has ensured the smooth operation and continuous development of the project. TOKYO, Sept. 20, 2024 /PRNewswire/ — TeraBox (“TeraBox” or “the Company”), a globally trusted cloud storage service headquartered in Tokyo, recently celebrated the second anniversary of its hugely popular Referral Program, […]
YANGZHOU, China, Sept. 21, 2024 /PRNewswire/ — Meihua International Medical Technologies Co., Ltd. (“MHUA” or the “Company”) (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today reported its unaudited financial results for the six months ended June 30, 2024. All amounts below […]
STOCKHOLM, Sept. 21, 2024 /PRNewswire/ — Ericsson (NASDAQ: ERIC) today announces that Carolina Dybeck Happe has decided to resign from its Board of Directors. Dybeck Happe has served on Ericsson’s Board since 2022. The announcement follows the September 12 appointment of Dybeck Happe to the position of Executive Vice President and Chief Operations Officer with […]
Beauty looks created by Lynsey Alexander, Global Creative Makeup Artist of Prada Beauty MILAN, Sept. 21, 2024 /PRNewswire/ — The Prada Spring/Summer 2025 Womenswear fashion show was held on September 19, 2024 inside the Deposito at Fondazione Prada, Milan. To view the Multimedia News Release, please click: https://www2.multivu.com/prada/9292351-en-gb-spring-summer-2025-womenswear-show **FACE** Alexander starts by preparing the skin with Prada Skincare, […]
NEW YORK, Sept. 20, 2024 /PRNewswire/ — Fosi Audio, a beloved brand among audiophiles worldwide, has officially launched its grand 7th-anniversary celebration under the theme “Your Voice Rocks & Sparks.” This milestone event has garnered significant attention within the audio community, with well-known audio reviewers and influencers such as Cheapaudioman, Z Reviews, Utilitarian TV, and numerous […]
Pr Newswire
Samsung Bioepis and Biogen Receive Positive CHMP Opinion for Aflibercept Biosimilar, OPUVIZ™
20
Sep
Sep
OPUVIZ™, a biosimilar referencing Eylea1 (aflibercept), is Samsung Bioepis and Biogen’s second ophthalmology biosimilar to be recommended for marketing authorization by the European Medicines Agency INCHEON, South Korea and CAMBRIDGE, Mass., Sept. 20, 2024 (GLOBE NEWSWIRE) — Samsung Bioepis Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) today announced that the European Medicines Agency’s (EMA) Committee […]
Pr Newswire
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old
20
Sep
Sep
Recommendation based on a Phase 3 trial showing a significantly greater proportion of children on Dupixent achieved histological remission compared to placebo, consistent with improvements seen in adults and adolescents If approved, Dupixent would be the first and only medicine in the EU indicated for EoE in this age group TARRYTOWN, N.Y. and PARIS, Sept. […]
Pr Newswire
Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old
20
Sep
Sep
Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Recommendation based on a phase 3 study showing a significantly greater proportion of children on Dupixent achieved histological remission, compared to placebo, consistent with improvements seen in adults and adolescents If approved, Dupixent would be […]